FONT-SIZE Plus   Neg

Schibsted Media Posts Loss In Q3 - Quick Facts

Schibsted Media Group (SBSNF.PK) Wednesday reported a loss for the third quarter, amid higher costs as well as increased tax rate.

Loss attributable to owners of the parent was 78 million Norwegian kroner or 0.73 kroner per share compared to a profit of 205 million kroner or 1.91 kroner per share last year. The prior-year results have been restated.

Adjusted earnings per share were 1.26 kroner while it totaled 2.00 kroner last year.

Pre-tax profit plunged to 33 million kroner from 338 million kroner in the previous year. EBITDA slid to 437 million kroner from 518 million kroner.

Operating revenues grew to 3.65 billion kroner from 3.52 billion kroner in the prior year.

The underlying revenue growth was 2 percent. The Online classifieds segments increased underlying revenues with 13 percent, and 17 percent excluding Spain.

Excluding Online classifieds Investment phase, the EBITDA was 672 million kroner, 4 percent higher than in the same period in 2012.

According to teh company, the tax rate was higher as a result of losses in startup operations for which no deferred tax assets are recognized. In addition, there are no tax benefits linked to the loss on the sale of Eesti Meedia.

Further, costs increased due to higher levels of activity in the growing online operations.

Schibsted sees continued revenue growth potential and a good margin outlook for its portfolio of established Online classifieds sites.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Consumer goods giant Procter & Gamble Co. on Tuesday reported a 4 percent increase in profit for the first quarter from last year on a slight decline in sales. However, both revenue and core earnings per share for the quarter beat analysts' estimates. In addition, the company affirmed its financial outlook for fiscal 2017. Merck & Co. Inc. (MRK) reported a profit for the third-quarter that increased about 20 percent, while quarterly worldwide sales grew 5 percent. The company raised its full-year 2016 outlook. Drug maker Eli Lilly and Co. reported Tuesday lower profit in its third quarter, despite higher revenues. Adjusted earnings per share and top line missed analysts' estimates. Further, for fiscal 2016, the company trimmed its forecast for reported earnings, while maintained adjusted earnings view, and raised revenue forecast.
comments powered by Disqus
Follow RTT